Novel agents for the treatment of resistant Gram-positive infections

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 117-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel antibacterial agents for the treatment of serious Gram-positive infections

By Abbanat Darren Macielag Mark Bush Karen

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 379-399

Informa Healthcare

Access to resources Recommend Favorite

Daptomycin - a novel antibacterial in the fight against resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Tigecycline for the treatment of infections due to resistant Gram-positive organisms

By Squires Ronald A Postier Russell G

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 155-162

Informa Healthcare

Access to resources Recommend Favorite

Daptomycin - a new option for resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Daptomycin: a novel agent for Gram-positive infections

By Tally F.P. Zeckel M. Wasilewski M.M. Carini C. Berman C.L. Drusano G.L. Oleson F.B.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1223-1238

Informa Healthcare

Access to resources Recommend Favorite